AHD Partners and Clients
Assurance Health Data partners with some of the most well-established partners in the health and pharma industries.
Nashville Biosciences is a clinical big data, genomics and medical imaging company accelerating the R&D activity of partners in the biopharmaceutical, diagnostics, and AI industries.
The Personalized Medicine Coalition, representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems.
MATTER is a global healthcare startup incubator, community nexus and corporate innovation accelerator headquartered in Chicago. Together, we are mobilizing a community of entrepreneurs, industry innovators, scientists and clinicians committed to improving health and care for every patient.
Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) is a continuing forum where public and private sector members work together to achieve common objectives and leverage collective opportunities to accelerate the development of precision medicine practices as a standard of care.
Blockchain in Healthcare Today (BHTY) is the world’s first peer reviewed journal that amplifies and disseminates distributed ledger technology research and innovations in the healthcare, information systems, clinical computing and network technologies and biomedical sciences sector.
The Illinois Chamber is dedicated to strengthening Illinois’ business climate and economy for the state’s job creators. It provides businesses a voice in the capitol, to work with lawmakers to make business-policy decisions, so employers can grow and add jobs, strengthening Illinois’ economy.
The Technology Council seeks to aggressively and proactively promote the interests of the Illinois technology community by advocating for public policy that fosters innovation and promotes economic growth. The Council will seek to promote workforce development policies, advocate for world-class technology infrastructure, avoid overregulation on the industry and support innovators’ access to the capital they need to grow.
Cofactor’s products use Predictive Immune Modeling, which leverages RNA data and machine learning to combine biological signals, creating multidimensional biomarkers to deliver on the promise of precision medicine. Cofactor Genomics offers its full-service molecular, informatic, and database tools to make drug discovery, clinical trials and therapy selection more successful.
PIcc is a regulatory science initiative that aims to facilitate innovations in pathology as well as advance safety and effectiveness evaluation, and to harmonize approaches to speed delivery to patients using collaborative, pre-competitive approaches. The collaborative community (PIcc) is open to all stakeholders, public or private, including, but not limited to, academia, industry, health care providers, patients and advocacy groups.
Graticule partners with Health Information Technology (HIT) vendors, health systems, and data marketplaces to power studies with deeper data sets to extend beyond claims and structured EHR records. Our approach allows teams to incorporate unstructured data, images, and longitudinal views with the power to translate into biomarker discoveries, rare disease detection, medical device safety surveillance, synthetic control arms, and quality of life reimbursement justifications.
After decades helping the world’s largest healthcare organizations and collaborating with leading academic institutions, Asher Orion’s goal is to make a tangible difference to innovators and investors who are pushing the boundaries of improving healthcare with AI.
Bioeconomy.XYZ is the Medium publication for biotechnology and everyone involved in the revolution. The best brought to you by the brightest.
Cancer Commons, a patient-centric nonprofit, features compassionate experts who build relationships with advanced cancer patients and caregivers to create personalized action plans. Our nurse navigators, PhD scientists, and national experts consult the latest, most-promising research to identify, explain, and help patients access their best-possible diagnostic and treatment options—so everyone feels confident they’ve left no stone unturned.
The xCures platform and its direct-to-patient connection generates Real-time, Regulatory-grade, Clinical (RRC) data that can be used for many different oncology studies and programs, accelerating the development of cancer treatments in the US.
Become A Partner
Return to Top